EE03426B1 - Risperidooni vesilahuselised ravimvormid - Google Patents
Risperidooni vesilahuselised ravimvormidInfo
- Publication number
- EE03426B1 EE03426B1 EE9700009A EE9700009A EE03426B1 EE 03426 B1 EE03426 B1 EE 03426B1 EE 9700009 A EE9700009 A EE 9700009A EE 9700009 A EE9700009 A EE 9700009A EE 03426 B1 EE03426 B1 EE 03426B1
- Authority
- EE
- Estonia
- Prior art keywords
- risperidone
- aqueous formulations
- formulations
- aqueous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/272,462 US5453425A (en) | 1994-07-11 | 1994-07-11 | Risperidone oral formulation |
US08/429,435 US5616587A (en) | 1994-07-11 | 1995-04-26 | Aqueous risperidone formulations |
PCT/EP1995/002615 WO1996001652A1 (fr) | 1994-07-11 | 1995-07-04 | Formulations aqueuses de risperidone |
Publications (2)
Publication Number | Publication Date |
---|---|
EE9700009A EE9700009A (et) | 1997-08-15 |
EE03426B1 true EE03426B1 (et) | 2001-06-15 |
Family
ID=26955530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EE9700009A EE03426B1 (et) | 1994-07-11 | 1995-07-04 | Risperidooni vesilahuselised ravimvormid |
Country Status (37)
Country | Link |
---|---|
US (3) | US5453425A (fr) |
EP (1) | EP0769965B1 (fr) |
JP (1) | JP2872412B2 (fr) |
KR (1) | KR100212942B1 (fr) |
CN (1) | CN1148226C (fr) |
AP (1) | AP774A (fr) |
AT (1) | ATE206931T1 (fr) |
AU (1) | AU684193B2 (fr) |
BG (1) | BG63070B1 (fr) |
BR (1) | BR9508253A (fr) |
CA (1) | CA2194564C (fr) |
CY (1) | CY2268B1 (fr) |
CZ (1) | CZ285204B6 (fr) |
DE (1) | DE69523313T2 (fr) |
DK (1) | DK0769965T3 (fr) |
EE (1) | EE03426B1 (fr) |
ES (1) | ES2165918T3 (fr) |
FI (1) | FI116510B (fr) |
HK (1) | HK1010691A1 (fr) |
HR (1) | HRP950397B1 (fr) |
HU (1) | HU222352B1 (fr) |
IL (1) | IL114525A (fr) |
MX (1) | MX9700374A (fr) |
MY (1) | MY114389A (fr) |
NO (1) | NO320366B1 (fr) |
NZ (1) | NZ289432A (fr) |
PH (1) | PH31626A (fr) |
PL (1) | PL179972B1 (fr) |
PT (1) | PT769965E (fr) |
RO (1) | RO116778B1 (fr) |
RU (1) | RU2161965C2 (fr) |
SI (1) | SI9500220B (fr) |
SK (1) | SK282159B6 (fr) |
TR (1) | TR199500778A1 (fr) |
TW (1) | TW420615B (fr) |
WO (1) | WO1996001652A1 (fr) |
ZA (1) | ZA955720B (fr) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995013814A1 (fr) | 1993-11-19 | 1995-05-26 | Janssen Pharmaceutica N.V. | 1,2-benzisoxazoles et 1,2-benzisothiazoles microencapsules et substitues par 3-piperidinyle |
US5453425A (en) * | 1994-07-11 | 1995-09-26 | Janssen Pharmaceutica N.V. | Risperidone oral formulation |
UA72189C2 (uk) | 1997-11-17 | 2005-02-15 | Янссен Фармацевтика Н.В. | Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот |
US6682758B1 (en) | 1998-12-22 | 2004-01-27 | The United States Of America As Represented By The Department Of Health And Human Services | Water-insoluble drug delivery system |
US6495164B1 (en) * | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
US20060148826A1 (en) * | 2002-08-23 | 2006-07-06 | Ashish Gogia | Stable aqueous solutions of risperidone and methods for their preparation |
WO2004094415A1 (fr) * | 2003-04-22 | 2004-11-04 | Synthon B.V. | Monochlorhydrates de risperidone |
PE20050285A1 (es) | 2003-06-24 | 2005-06-09 | Novartis Ag | Composicion farmaceutica que comprende analogos ciclicos de somatostatina |
US20050036977A1 (en) * | 2003-08-11 | 2005-02-17 | Dilip Gole | Taste-masked resinate and preparation thereof |
ES2245252B1 (es) * | 2004-06-15 | 2007-03-01 | Farmalider, S.A. | Solucion acuosa de risperidona para administracion oral. |
ES2245891B1 (es) * | 2004-07-09 | 2006-11-16 | Clinmet S.L. | "metodo para la obtencion de un excipiente universal para la administracion oral de principios activos farmaceuticos y composiciones de excipientes resultantes del metodo". |
WO2006129160A2 (fr) * | 2005-06-01 | 2006-12-07 | Aurobindo Pharma Limited | Solutions aqueuses stables d'un agent antipsychotique |
ATE424399T1 (de) * | 2005-06-29 | 2009-03-15 | Verisfield Uk Ltd | Pharmazeutische zusammensetzungen von risperidon in wässriger lösung |
US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
JP4922657B2 (ja) * | 2006-05-09 | 2012-04-25 | 高田製薬株式会社 | リスペリドン経口用液剤 |
WO2007138462A2 (fr) * | 2006-06-01 | 2007-12-06 | Wockhardt Ltd | Formulations orales aqueuses de rispéridone |
MX354603B (es) | 2007-05-25 | 2018-03-13 | Indivior Uk Ltd | Formulaciones de transferencia sostenida de compuestos de risperidona. |
US7776866B2 (en) * | 2007-09-15 | 2010-08-17 | Protia, Llc | Deuterium-enriched risperidone |
LT2234617T (lt) * | 2007-12-19 | 2021-05-25 | Janssen Pharmaceutica Nv | Dozės režimai, susiję su ilgo veikimo injekuojamais paliperidono esteriais |
WO2010085452A1 (fr) | 2009-01-20 | 2010-07-29 | Los Angeles Biomedical Research Institute At Harbor - Ucla Medical Center | Acide sorbique et benzoïque et dérivés de celui-ci pour améliorer l'activité d'un produit neuropharmaceutique |
GB2481017B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
EP2763676B1 (fr) * | 2011-10-03 | 2019-12-25 | The University of Utah Research Foundation | Application d'antagonistes du récepteur 5-ht6 dans l'atténuation des déficits cognitifs liés au syndrome de down |
GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
US20160128997A1 (en) | 2014-11-07 | 2016-05-12 | Indivior Uk Limited | Sustained-release buprenorphine formulations |
CN109563024B (zh) | 2016-06-13 | 2023-06-06 | 心悦生医股份有限公司 | 苯甲酸锂的共晶及其用途 |
FI3468944T3 (fi) | 2016-06-13 | 2023-01-31 | Natriumbentsoaatin yhteiskiteitä ja niiden käyttöjä | |
KR20190066608A (ko) * | 2016-09-23 | 2019-06-13 | 델포어, 인코포레이티드 | 소분자 치료제 화합물 조성물 |
US10336679B2 (en) | 2016-10-24 | 2019-07-02 | Syneurx International (Taiwan) Corp. | Polymorphic forms of sodium benzoate and uses thereof |
RU2646812C1 (ru) * | 2016-10-24 | 2018-03-07 | Общество с ограниченной ответственностью "Трейдсервис" | Жидкая лекарственная форма рисперидона и способ ее получения |
US11369579B2 (en) | 2016-10-24 | 2022-06-28 | Syneurx International (Taiwan) Corp. | Polymorphic forms of sodium benzoate and uses thereof |
US10646484B2 (en) | 2017-06-16 | 2020-05-12 | Indivior Uk Limited | Methods to treat opioid use disorder |
CN107260662A (zh) * | 2017-06-21 | 2017-10-20 | 南京正科医药股份有限公司 | 一种利培酮口服溶液及其制备方法 |
CN107441037A (zh) * | 2017-08-16 | 2017-12-08 | 南京正科医药股份有限公司 | 一种利培酮口服溶液 |
CN109589304A (zh) * | 2017-10-01 | 2019-04-09 | 万特制药(海南)有限公司 | 利培酮口服溶液及其制备方法 |
US10098861B1 (en) | 2017-10-24 | 2018-10-16 | Syneurx International (Taiwan) Corp. | Pharmaceutical composition comprising sodium benzoate compound and clozapine, and uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4337261A (en) * | 1980-07-28 | 1982-06-29 | Hoechst-Roussel Pharmaceuticals Inc. | (1,2-Benzisoxazol)phenoxyacetic acids as diuretics |
IL88233A (en) * | 1987-11-03 | 1993-08-18 | Genentech Inc | Gamma interferon formulation |
FR2641278B1 (fr) * | 1989-01-05 | 1991-03-22 | Lipha | Piperidines, procedes de preparation et medicaments les contenant |
DK203990D0 (da) * | 1990-08-24 | 1990-08-24 | Novo Nordisk As | Piperazinylderivater |
TW376319B (en) * | 1993-04-28 | 1999-12-11 | Janssen Pharmaceutica Nv | Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine |
US5453425A (en) * | 1994-07-11 | 1995-09-26 | Janssen Pharmaceutica N.V. | Risperidone oral formulation |
FR2796273B1 (fr) * | 1999-07-15 | 2003-09-12 | Oreal | Composition a phase grasse liquide gelifiee par un polyamide a groupements ester terminaux |
-
1994
- 1994-07-11 US US08/272,462 patent/US5453425A/en not_active Expired - Lifetime
-
1995
- 1995-04-26 US US08/429,435 patent/US5616587A/en not_active Ceased
- 1995-05-19 TW TW084104959A patent/TW420615B/zh not_active IP Right Cessation
- 1995-05-31 PH PH50624A patent/PH31626A/en unknown
- 1995-06-29 TR TR95/00778A patent/TR199500778A1/xx unknown
- 1995-07-04 DK DK95924978T patent/DK0769965T3/da active
- 1995-07-04 PL PL95318132A patent/PL179972B1/pl unknown
- 1995-07-04 EP EP95924978A patent/EP0769965B1/fr not_active Expired - Lifetime
- 1995-07-04 AU AU29275/95A patent/AU684193B2/en not_active Expired
- 1995-07-04 AT AT95924978T patent/ATE206931T1/de active
- 1995-07-04 JP JP8504108A patent/JP2872412B2/ja not_active Expired - Lifetime
- 1995-07-04 CN CNB951940821A patent/CN1148226C/zh not_active Expired - Lifetime
- 1995-07-04 BR BR9508253A patent/BR9508253A/pt not_active IP Right Cessation
- 1995-07-04 CZ CZ9727A patent/CZ285204B6/cs not_active IP Right Cessation
- 1995-07-04 PT PT95924978T patent/PT769965E/pt unknown
- 1995-07-04 AP APAP/P/1997/000910A patent/AP774A/en active
- 1995-07-04 HU HU9700082A patent/HU222352B1/hu active IP Right Grant
- 1995-07-04 ES ES95924978T patent/ES2165918T3/es not_active Expired - Lifetime
- 1995-07-04 MX MX9700374A patent/MX9700374A/es unknown
- 1995-07-04 RO RO97-00032A patent/RO116778B1/ro unknown
- 1995-07-04 SK SK22-97A patent/SK282159B6/sk not_active IP Right Cessation
- 1995-07-04 NZ NZ289432A patent/NZ289432A/en not_active IP Right Cessation
- 1995-07-04 EE EE9700009A patent/EE03426B1/xx unknown
- 1995-07-04 RU RU97102139/14A patent/RU2161965C2/ru active
- 1995-07-04 WO PCT/EP1995/002615 patent/WO1996001652A1/fr active IP Right Grant
- 1995-07-04 DE DE69523313T patent/DE69523313T2/de not_active Expired - Lifetime
- 1995-07-04 KR KR1019970700039A patent/KR100212942B1/ko not_active IP Right Cessation
- 1995-07-04 CA CA002194564A patent/CA2194564C/fr not_active Expired - Lifetime
- 1995-07-10 SI SI9500220A patent/SI9500220B/sl active Search and Examination
- 1995-07-10 IL IL11452595A patent/IL114525A/xx not_active IP Right Cessation
- 1995-07-10 ZA ZA955720A patent/ZA955720B/xx unknown
- 1995-07-10 HR HR950397A patent/HRP950397B1/xx not_active IP Right Cessation
- 1995-07-11 MY MYPI95001944A patent/MY114389A/en unknown
-
1997
- 1997-01-04 BG BG101106A patent/BG63070B1/bg active Active
- 1997-01-07 NO NO19970051A patent/NO320366B1/no not_active IP Right Cessation
- 1997-01-10 FI FI970109A patent/FI116510B/fi not_active IP Right Cessation
-
1998
- 1998-10-29 HK HK98111584A patent/HK1010691A1/xx not_active IP Right Cessation
-
2001
- 2001-12-04 US US09/955,274 patent/USRE39181E1/en not_active Expired - Lifetime
-
2002
- 2002-04-25 CY CY0200019A patent/CY2268B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE03426B1 (et) | Risperidooni vesilahuselised ravimvormid | |
BR9510256A (pt) | Derivados de ácido 3-aril-tetrônico | |
NO986208D0 (no) | Vandige peptidformuleringer | |
NO950785D0 (no) | Fettsyrederivater | |
IS2325B (is) | Örgerðar samsetningar epleróns | |
ATE248812T1 (de) | Arylsulfonylhydroxamsäurederivate | |
DE69518331D1 (de) | Orale zubereitungen | |
BR9507179A (pt) | Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena | |
EE9500059A (et) | Asendatud 4-fenüül-6-aminonikotiinhappe derivaatide kasutamine ravimitena | |
NO306350B1 (no) | Vandig rengjöringspreparat | |
DE69732787D1 (de) | Wässrige körperreinigungsmittelzusammensetzung | |
FI964193A (fi) | Puriinien valmistaminen | |
IT1276799B1 (it) | Formulazioni di f-silicone | |
DE69524611D1 (de) | Pyrimidon-derivate | |
DE69619640D1 (de) | Wässrige Austrichstoffe | |
ITMI20011389A0 (it) | Formulazioni farmaceutiche acquose di cromoglicato sodico | |
DE69432149D1 (de) | Orale Zubereitungen | |
ITMI941169A0 (it) | Formulazioni farmaceutiche | |
FI953580A (fi) | Asyklovirin valmistus | |
FI950103A (fi) | Vesipitoiset hammaspuhdistusaineet | |
SE9404467D0 (sv) | Drug formulations | |
ITRM920116A0 (it) | Formulazioni liposomiche di piroxicam. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20091231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20101231 |